NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,000 | -44.4% | 363 | -27.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | 0.0% | 497 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +50.0% | 497 | +67.3% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +20.0% | 297 | +8.4% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 274 | +5.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -33.3% | 261 | +5.7% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | 0.0% | 247 | -27.4% | 0.00% | -50.0% |
| Q1 2020 | $6,000 | -81.8% | 340 | -78.1% | 0.00% | -75.0% |
| Q4 2019 | $33,000 | +13.8% | 1,550 | -3.8% | 0.01% | +14.3% |
| Q3 2019 | $29,000 | -40.8% | 1,611 | +15.9% | 0.01% | -46.2% |
| Q2 2019 | $49,000 | +512.5% | 1,390 | +476.8% | 0.01% | +550.0% |
| Q1 2019 | $8,000 | 0.0% | 241 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $8,000 | -60.0% | 241 | -27.6% | 0.00% | -66.7% |
| Q3 2018 | $20,000 | -16.7% | 333 | -32.2% | 0.01% | -25.0% |
| Q2 2018 | $24,000 | -54.7% | 491 | -2.4% | 0.01% | -55.6% |
| Q1 2018 | $53,000 | +82.8% | 503 | +2.4% | 0.02% | +80.0% |
| Q4 2017 | $29,000 | +163.6% | 491 | +5.6% | 0.01% | +150.0% |
| Q3 2017 | $11,000 | +22.2% | 465 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | -18.2% | 465 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $11,000 | +83.3% | 465 | 0.0% | 0.01% | +66.7% |
| Q4 2016 | $6,000 | -25.0% | 465 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $8,000 | +14.3% | 465 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $7,000 | +40.0% | 465 | +16.5% | 0.00% | +33.3% |
| Q1 2016 | $5,000 | -76.2% | 399 | -68.6% | 0.00% | -75.0% |
| Q4 2015 | $21,000 | +950.0% | 1,270 | +513.5% | 0.01% | +1100.0% |
| Q3 2015 | $2,000 | – | 207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |